6-diazo-5-oxo-l-norleucine prodrugs
Prange, Céline Jasmin; Hu, Xile; Tang, Li; Ben Sayed, Nadia Yasmina
2024

Abstract

The present invention relates to 6-diazo-5-oxo-L-norleucine prodrugs having reduced toxicity and increased tumor specificity and to their therapeutic use for treating cancer.

Details

Title 6-diazo-5-oxo-l-norleucine prodrugs
Author(s) Prange, Céline Jasmin ; Hu, Xile ; Tang, Li ; Ben Sayed, Nadia Yasmina
Date 2024
Keywords
Note Alternative title(s) : (fr) Promédicaments de 6-diazo-5-oxo-l-norleucine
Other identifier(s) EPO Family ID: 84329966
Patent number(s) WO2024094526 (A1)
Laboratories TTO
Record Appears in Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date 2024-06-03